Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc shares valued at $1,635,864 were sold by AFEYAN NOUBAR on Mar 27 ’24. At $109.06 per share, AFEYAN NOUBAR sold 15,000 shares. The insider’s holdings dropped to 2,101,931 shares worth approximately $214.96 million following the completion of this transaction.
Also, AFEYAN NOUBAR sold 15,000 shares, netting a total of over 1,535,820 in proceeds. Following the sale of shares at $102.39 each, the insider now holds 2,116,931 shares.
Before that, Hoge Stephen had sold 15,000 shares from its account. In a trade valued at $1,547,550, the President traded Moderna Inc shares for $103.17 each. Upon closing the transaction, the insider’s holdings decreased to 15,000 shares, worth approximately $153.53 million.
As published in a research note from HSBC Securities on February 26, 2024, Moderna Inc [MRNA] has been rated down from a Hold to a Reduce and the price target has been revised to $86 from $75. Analysts at Oppenheimer upgraded the stock from ‘”a Perform”‘ to ‘”an Outperform”‘ outlook in a report released in early January. As of November 29, 2023, Canaccord Genuity has initiated its “Hold” rating for MRNA. Earlier on November 03, 2023, HSBC Securities upgraded its rating. Their new recommendation was “a Hold” for MRNA stock which previously was a “a Reduce”.
Analyzing MRNA Stock Performance
During the last five days, there has been a drop of approximately -7.52%. Over the course of the year, Moderna Inc shares have jumped approximately 2.84%. Shares of the company reached a 52-week high of $115.97 on 01/08/24 and a 52-week low of $84.06 on 02/13/24. A 50-day SMA is recorded $99.40, while a 200-day SMA reached $99.90. Nevertheless, trading volume fell to 3.08 million shares from 2.6 million shares the previous day.
Support And Resistance Levels for Moderna Inc (MRNA)
According to the 24-hour chart, there is a support level at 100.67, which, if violated, would cause prices to drop to 99.06. In the upper region, resistance lies at 104.93. The next price resistance is at 107.58. RSI (Relative Strength Index) is 48.94 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.88, which suggests the price will decrease in the coming days. Percent R is at 64.87%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Moderna Inc subject to short interest?
Stocks of Moderna Inc saw a sharp steep in short interest on Mar 15, 2024 dropping by -1.85 million shares to 22.23 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 24.08 million shares. A decline of -8.32% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.78 of the overall float, the days-to-cover ratio (short ratio) decline to 4.78.
